...
首页> 外文期刊>Neuroscience: An International Journal under the Editorial Direction of IBRO >Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.
【24h】

Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra.

机译:逆行信号改变了大鼠黑质中突触后抑制的位置。

获取原文
获取原文并翻译 | 示例

摘要

Both endocannabinoids through cannabinoid receptor type I (CB1) receptors and dopamine through dopamine receptor type D1 receptors modulate postsynaptic inhibition in substantia nigra by changing GABA release from striatonigral terminals. By recording from visually identified pars compacta and pars reticulata neurons we searched for a possible co-release and interaction of endocannabinoids and dopamine. Depolarization of a neuron in pars reticulata or in pars compacta transiently suppressed evoked synaptic currents which were blocked by GABA(A) receptor antagonists (inhibitory postsynaptic currents [IPSCs]). This depolarization-induced suppression of inhibition (DSI) was abrogated by the cannabinoid CB1 receptor antagonist AM251 (1 microM). A correlation existed between the degree of DSI and the degree of reduction of evoked IPSCs by the CB1 receptor agonist WIN55,212-2 (1 microM). The cholinergic receptor agonist carbachol (0.5-5 microM) enhanced DSI, but suppression of spontaneous IPSCs was barely detectable pointing to the existence of GABA release sites without CB1 receptors. In dopamine, but not in GABAergic neurons DSI was enhanced by the dopamine D1 receptor antagonist SCH23390 (3-10 microM). Both the antagonist for CB1 receptors and the antagonist for dopamine D1 receptors enhanced or reduced, respectively, the amplitudes of evoked IPSCs. This tonic influence persisted if the receptor for the other ligand was blocked. We conclude that endocannabinoids and dopamine can be co-released. Retrograde signaling through endocannabinoids and dopamine changes inhibition independently from each other. Activation of dopamine D1 receptors emphasizes extrinsic inhibition and activation of CB1 receptors promotes intrinsic inhibition.
机译:通过I型大麻受体(CB1)受体的内源性大麻素和通过D1型受体多巴胺的多巴胺都通过改变从纹状体顶末端释放的GABA来调节黑质中的突触后抑制。通过从视觉上识别的帕斯紧密连接和网状帕拉神经元记录,我们搜索了内源性大麻素和多巴胺可能的共释放和相互作用。网状体或腮腺中的神经元去极化可暂时抑制诱发的突触电流,该突触电流被GABA(A)受体拮抗剂阻断(抑制性突触后电流[IPSC])。大麻素CB1受体拮抗剂AM251(1 microM)废除了这种去极化诱导的抑制抑制作用(DSI)。 CB1受体激动剂WIN55,212-2(1 microM)在DSI的程度和诱发的IPSC的减少程度之间存在相关性。胆碱能受体激动剂卡巴胆碱(0.5-5 microM)增强了DSI,但几乎检测不到自发IPSC的抑制作用,这表明存在不含CB1受体的GABA释放位点。在多巴胺中,而不是在GABA能神经元中,多巴胺D1受体拮抗剂SCH23390(3-10 microM)增强了DSI。 CB1受体拮抗剂和多巴胺D1受体拮抗剂分别增强或降低了诱发的IPSC的振幅。如果其他配体的受体被阻断,这种滋补作用将持续存在。我们得出结论,内源性大麻素和多巴胺可以共释放。通过内源性大麻素和多巴胺的逆行信号相互独立地改变抑制作用。多巴胺D1受体的激活强调外在抑制,而CB1受体的激活则促进内在抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号